Spasticity
Bailey Frei
Background
- Spasticity is a velocity-dependent increase in resistance to passive stretch.
- It differs from hypertonia, which is resistance to passive stretch that is not velocity-dependent
- Spasticity is believed to result from disruption of descending inhibitory modulation of the alpha motor neurons by an upper motor lesion, producing hyperexcitability
- Grading (by the Modified Ashworth Scale)
- 0: no increase in tone
- 1: slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of ROM when affected part is moved in flexion or extension
- 1+: slight increase in muscle tone, manifested by a catch followed by minimal resistance through the remainder of ROM (less than 50%)
- 2: more marked increase in muscle tone through most of ROM, but affected part is easily moved
- 3: considerable increases in muscle tone; passive movement difficult
- 4: affected part is rigid in flexion or extension
Management
- Spasticity can have functional benefits, including improving standing and transfers. However, it can also cause weakness, poor dexterity, pain, and contractures.
- If spasticity is having undesirable effects, the first line of treatment is PT/OT and physical modalities such as stretching.
- Oral medications are the next line of treatment.
Medication |
Mechanism of Action |
Side Effects/Important Considerations |
|---|---|---|
| Baclofen | GABA-B agonist | sedation, fatigue, nausea, centrally acting – risk of withdrawal |
| Tizanidine | Alpha-2 agonist | sedation, dizziness, xerostomia, weakness, centrally acting – risk of withdrawal |
| Diazepam/ Benzodiazepines | GABA-A agonist | sedation, confusion, hypotension, centrally acting – risk of withdrawal |
| Dantrolene | inhibits Ca release from sarcoplasmic reticulum | weakness, sedation, nausea, hepatotoxicity, acts directly on skeletal muscle |
- Intrathecal baclofen: reserved for pts who have significant side effects with oral anti-spasticity medications or who have severe, persistent, and diffuse spasticity despite maximal doses
- Injections
- Botulinum toxin: Blocks the presynaptic release of acetylcholine from motor endplates of the lower motor neuron at the myoneural junction. Effect usually lasts 3-8months
- Alcohol block: Phenol and ethanol are neurolytic agents that can be used to block nerves with motor function.
- Surgeries
- Selective dorsal rhizotomy, osteotomy, muscle tendon lengthening, release, or transfer
***If a pt experiences worsening of spasticity, it is important to consider other underlying conditions such as infections, pressure ulcers, constipation, or bladder distention***
